About the Journal


Aims and scope

Mediastinum (ISSN 2522-6711) is an open access and peer-reviewed medical journal aiming at better understanding and management of mediastinal diseases. It is a professional platform for the sharing of knowledge and experience between interested peers so as to finally benefit the patients. As a unique journal, it is not limited to diseases primary to this narrow space, but encompassing all disorders related to or affecting the mediastinum (including metastatic lesions from other parts of the body, local manifestation of systemic changes, as well as disease extension from neighboring organs or compartments). By allocating most up-to-date clinical and basic researches, state-of-the-art therapeutic approaches, and rich material for education, Mediastinum aims to provide high level evidence and useful resources for all healthcare professionals engaged in delivering quality care to their mediastinal patients.

Submission Turnaround Time:
Submission to First Editorial Decision: 2-4 weeks.
External peer review: 1-3 months.
Acceptance to Publication: 2-4 weeks. Original Articles are listed as priority.

AME Publishing Company
Address: Rm C, 16/F, Kings Wing Plaza 1, No. 3 On Kwan Street, Shatin, NT, Hong Kong
Phone: +86 20 66355775
Email: med@amegroups.com

Updated on September 19, 2019